VA Medical Center and UC College of Medicine Create General Clinical Research Center
The Department of Veterans Affairs (VA) Medical Center, Cincinnati, and the University of Cincinnati (UC) College of Medicine have established a site to study adults with complex medical or psychiatric disorders. The new site, named the General Clinical Research Center (GCRC), will accommodate studies from a variety of sponsors including the National Institutes of Health (NIH) and the VA Research Programs. A ribbon cutting ceremony will be held on April 15 at 1:00 p.m. in the GCRC located on the 4th floor of the Cincinnati VA. This ceremony is open to the public.
The GCRC offers a wide range of support to researchers including assistance with grant preparation and submission, Institutional Review Board and VA Research and Development Committee submission and processing, grant budgets and contracts, study assessments, and study logistics.
The GCRC space is made up of two monitored rooms for inpatients, five outpatient examination rooms, an investigational pharmacy, a phlebotomy room, and a fully equipped cardiac physiology laboratory.
Stephen M. Strakowski, MD, professor in the UC Department of Psychiatry, was appointed by the Cincinnati VA as the director of the GCRC. VA Associate Directors of the GCRC are Dave D'Alessio, MD, associate professor in the UC Department of Internal Medicine/Division of Endocrinology; and Paul E. Keck, MD, professor in the UC Department of Psychiatry.
For more information contact the GCRC Administrator Amelia T. Nasrallah by phone at (513) 558-2226 or (513) 861-3100, ext. 4486, or e-mail
.
Related Stories
Can new research improve the safety of AI therapy for teens?
December 5, 2025
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition for a discussion on the growing trend of young people turning to artificial intelligence for mental health support and therapy.
Student-designed AI platform aims to match patients to specific cancer support groups
December 5, 2025
The University of Cincinnati is launching a clinical trial testing a student-designed, machine-learning powered platform to match patients with cancer to support groups specifically tailored to their needs and concerns.
What would expanded access to GLP-1s mean for the obesity rate?
December 4, 2025
The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.